Related Experiment Video
Updated: Jun 17, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Risk of cardiovascular disease in HIV-infected patients
1HIV & GU Medicine, Coventry Community Health Services, Stoney Stanton Road, Coventry CV1 4FH, UK. satyajit.das@coventrypct.nhs.uk
Insights
Highly active antiretroviral therapy (HAART) has significantly increased HIV life expectancy. Long-term HIV management now requires addressing age-related conditions like cardiovascular disease (CVD).
Area of Science:
- Infectious Diseases
- Cardiology
- Gerontology
Background:
- The advent of highly active antiretroviral therapy (HAART) has transformed HIV infection from a terminal illness into a chronic condition.
- Increased life expectancy for people with HIV necessitates a shift in treatment focus towards long-term health management.
- Age-associated comorbidities, particularly cardiovascular disease (CVD), are emerging as significant concerns in the aging HIV population.
Purpose of the Study:
- To explore and discuss the evidence linking HIV infection to increased cardiovascular risk.
- To examine the potential cardiovascular risks associated with antiretroviral therapy (ART).
- To highlight the importance of managing age-related diseases in long-term HIV care.
Main Methods:
- Literature review of studies investigating cardiovascular risk in HIV-infected individuals.
- Analysis of data on the association between specific antiretroviral drugs and cardiovascular events.
- Synthesis of current understanding regarding HIV-related inflammation and its impact on cardiovascular health.
Main Results:
- Evidence suggests that HIV infection itself is an independent risk factor for cardiovascular disease.
- Certain antiretroviral therapies may be associated with an elevated risk of cardiovascular complications.
- The interplay between HIV, aging, and traditional cardiovascular risk factors requires careful consideration.
Conclusions:
- Long-term management of HIV must prioritize the prevention and treatment of cardiovascular disease.
- Further research is needed to fully elucidate the mechanisms of cardiovascular risk in HIV and to optimize ART regimens for cardiovascular safety.
- A comprehensive approach integrating infectious disease and cardiovascular care is essential for improving outcomes in aging individuals with HIV.
Abstract:
The life expectancy of people living with HIV infection has improved dramatically since the use of highly active antiretroviral therapy (HAART). Now that patients with HIV infection are living longer, the focus of its treatment should shift to long-term management spanning decades. Diseases of ageing, including cardiovascular disease (CVD), have now become more important. The evidence of cardiovascular risk associated with HIV infection and antiretroviral therapy is explored and discussed in this article.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Related Concept Videos
Sexually Transmitted Infections
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Retrovirus Life Cycles
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...